Completed
A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid Tumors
NCT01999972
- Conditions
- Advanced Solid Tumors, Carcinoma, Neoplasms, +2 more
- Locations
-
- University of Chicago Medical Center Chicago, Illinois, United States
- Investigational Drug Services IUHSCC Indianapolis, Indiana, United States
- IU Health University Hospital Indianapolis, Indiana, United States
- Massachusetts General Hospital Boston, Massachusetts, United States